Removing opioid prescriptions from cataract surgery
Ophthalmology Times Europe,
To control pain and inflammation most effectively and responsibly for our cataract surgery patients, we must not only use the…
Let it rain: Premium surgeons can remain confident
Healio.com,
September 02, 2021 4 min read Source/Disclosures Published by: Disclosures: Jackson reports he is a consultant for Bausch + Lomb…
Let’s address the opioid crisis with the same resolve as Covid-19
Medcity News,
While Covid-19 was ravaging our country over the past year, America was also fighting another epidemic: the ongoing battle…
How to wean the Medicare system off opioids
Georgia Health News,
By Drs. Douglas Blackmon and David Paine Over the past few months, the COVID-19 pandemic has ravaged the world, our country…
Op-Ed: Americans Deserve Pain Management Beyond Opioids
MedPage Today,
Public Health
Advances in drug delivery: Less is more
Healio.com,
The world of perioperative medications associated with cataract surgery for the premium surgeon is evolving rapidly.
Cataract Surgical Patients Deserve Access to Safe, Effective Non-Opioid Alternatives
Morning Consult ,
Take, for example, patients with smaller pupils or those at risk for intraoperative floppy iris syndrome, a common side effect…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Biospace,
Nov. 4, 2019 12:50 UTC Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion SEATTLE--( BUSINESS…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Weather herald,
SEATTLE--()--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
NASDAQ,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- SEATTLE --(BUSINESS WIRE)-- Omeros…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
TulsaCW,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- SEATTLE --(BUSINESS WIRE) Omeros…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Fox 21 Delmarva,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- SEATTLE --(BUSINESS WIRE) Omeros…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Erie News Now,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- -- Study Demonstrates Opioid-Sparing…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Jotup,
The study objectives were to evaluate the effect of OMIDRIA compared to epinephrine on perioperative fentanyl use and pain in…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Wall Street Online Denmark,
Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study showing that its FDA-approved…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Digital Journal,
SEATTLE--(Business Wire)--Omeros Corporation (Nasdaq: OMER) today announced that results of a prospective, controlled study…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Benzinga,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- Omeros Corporation (NASDAQ:OMER…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Morning Star,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- Omeros Corporation (Nasdaq: OMER…
Omeros Corporation Announces Publication of Study Results on the Impact of OMIDRIA on Opioid Use and Pain
Business Wire,
-- Study Demonstrates Opioid-Sparing Requirement of OMIDRIA for CMS Packaging Exclusion -- SEATTLE--( BUSINESS WIRE )--Omeros…